We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
113 hedge funds and large institutions have $204M invested in Lexicon Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 26 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
38% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 26
20% more call options, than puts
Call options by funds: $293K | Put options by funds: $245K
5% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 22
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2% less funds holding
Funds holding: 115 → 113 (-2)
2.82% less ownership
Funds ownership: 100.86% → 98.04% (-2.8%)
54% less capital invested
Capital invested by funds: $445M → $204M (-$240M)
Holders
113
Holders Change
-2
Holders Change %
-1.74%
% of All Funds
2.49%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
23
Increased
36
Reduced
26
Closed
22
Calls
$293K
Puts
$245K
Net Calls
+$48K
Net Calls Change
-$768K
Top Buyers
Top Sellers
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$11.5M |
| 2 |
Millennium Management
New York
|
-$5.43M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$3.17M |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$1.96M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.84M |
